
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.12 | 7.14285714286 | 1.68 | 1.9 | 1.68 | 18545 | 1.79117324 | CS |
4 | -0.13 | -6.73575129534 | 1.93 | 2.04 | 1.61 | 17932 | 1.76632665 | CS |
12 | -0.28 | -13.4615384615 | 2.08 | 2.21 | 1.43 | 37713 | 1.89851356 | CS |
26 | -1.03 | -36.3957597173 | 2.83 | 3.67 | 1.43 | 33829 | 2.22788171 | CS |
52 | -3.2 | -64 | 5 | 5.97 | 1.43 | 44560 | 3.25432418 | CS |
156 | -14.58 | -89.010989011 | 16.38 | 16.38 | 1.17 | 21355 | 3.55050551 | CS |
260 | -14.58 | -89.010989011 | 16.38 | 16.38 | 1.17 | 13693 | 3.55050551 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions